This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked PEF1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PEF1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~30.4 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Ubl conjugation | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The M09591 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HeLa cell lysate (catalog M09591) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M09591; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
PEF1 is predicted at 30.4 kDa; its listed features do not demonstrate altered Western blot migration, so confirm any candidate band with identity controls.
| Band near 30.4 kDa in whole-cell lysate | Consistent with the predicted size of PEF1; identity still needs confirmation |
| Band near 30.4 kDa in a cytosolic fraction | Consistent with cytoplasmic PEF1 |
| Band near 30.4 kDa in a membrane fraction | Consistent with peripheral membrane-associated PEF1 |
| Band near 30.4 kDa in a COPII vesicle fraction | Consistent with PEF1 at COPII-coated vesicle membranes |
| Predicted molecular mass | Places full-length PEF1 near 30.4 kDa |
| 284-amino-acid sequence | Defines the full-length protein underlying the predicted mass |
| PDCD6 heterodimerization | Does not establish a higher band on a Western blot |
| Calcium-dependent dissociation from PDCD6 | Does not establish a change in apparent band size |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Peripheral membrane or vesicle-associated PEF1 may be poorly recovered | Check extraction and compare soluble and membrane fractions |
| Weak or no signal | Incomplete recovery of cytoplasmic or membrane-associated PEF1 | Check fraction recovery and use a positive control |
| Band higher than expected | The listed features do not establish a higher-migrating PEF1 species | Confirm band identity with knockdown or a second antibody |
| Band lower than expected | No signal-peptide or propeptide cleavage is annotated | Confirm band identity with knockdown or a second antibody |
| Multiple bands | The single annotated isoform does not establish multiple PEF1 bands | Identify the PEF1-dependent band with knockdown |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for PEF1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Both listed anti-PEF1 antibodies have WB images and reported human, mouse, and rat reactivity. M09591 is shown with HeLa lysate; A09591-2 shows an approximately 30 kDa band in eight human samples. No mouse or rat WB samples are shown.
Which to pick: For a HeLa example, consider M09591. For documented conditions across several human sample types, consider A09591-2: its image uses 50 µg of sample per lane under reducing conditions and 0.5 µg/mL primary antibody. Both list mouse and rat reactivity.